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(0/24). Based on the results obtained 
here, it seems that AGV2 is resistant 
to the action of disinfectants as CAV. 
The present work is still in progress. 
Analyzes on the material harvested 
from necropsy carried out on 30 dph 
are in processing. We believe that the 
results showed here contribute for a 
better understanding of AGV2 ecology, 
once the epidemiology, pathogenesis, 
routes of infection, transmission, 
as well the interaction agent-host-
environment of such virus are not 
satisfactory known yet. Financial 
support: Embrapa Swine and Poultry 
& CNPq KEYWORDS: AGV2; Infectivity, 
Chicken; Broiler Litter
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Infectious bronchitis virus (IBV) is the 
causative agent of highly contagious 
respiratory disease of chickens that 
affect mainly young chickens. Failure of 
protection as well as variation on clinical 
manifestations associated with the 
emergence of many different antigenic 
types of the IBV have been reported in 
the last years. Although vaccines may 
protect against heterologous strains, 
it has been speculated that the vaccine 
serotype Massachusetts has not always 
been able to confer full protection   ϐ   Ǥ
Through protectotyping studies in SPF 
chickens, the immune response against 
an IBV sample is evaluated. It has been 
hypothesized that broilers are more 
susceptible to the in vivo assay than 
SPF chicks. To evaluate the use of SPF 
chicks in vaccine protection against 
IB, we evaluated two parameters: 
ciliary activity and viral recovery for 
IBV with standard strain (M41) in two 
poultry lineages (SPF and broilers). 
The experimental design (for both 
lineages) follows: 1)non-vaccinated 
and non-challenged birds (NVNC) 
and 2)vaccinated and non-challenged 
birds (VNC); 3) challenged with 
Massachusets (CM41) and 4) vaccinated 
and challenged with Massachusets 
(VCM41). Groups 2 and 4 received two 
doses of 103.5DIE50% H120 vaccine 
strain by eyedrop at 14 and 21 days-Ǥϐ
weeks after vaccination. Degrees of 
ciliary activity, and viral recovery were 
measured at 5 days after challenge 
to assess the ability of the vaccine to 
protect the chicks in different lineages. 
The results obtained in the present ϐ
on the evaluated parameters (ciliary 
activity and viral recovery), supporting 
the use of SPF chicks for in vivo assay 
of IBV vaccine protection once the use 
of SPF birds facilitates the execution of 
such procedure in isolator chambers 
allowing the accommodation of larger 
number of birds due to its smaller size 
relative to the commercial poultry. 
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